AVITA Medical Inc.

NASDAQ: RCEL · Real-Time Price · USD
5.80
0.04 (0.69%)
At close: Aug 14, 2025, 3:59 PM
5.88
1.38%
After-hours: Aug 14, 2025, 04:28 PM EDT

AVITA Medical Revenue Breakdown

Period Ending Dec 31, 2024
Lease Revenue Revenue 358K
Lease Revenue Revenue Growth n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Jun 30, 2021 Jun 30, 2020
Australia Revenue 312K 222K 33.26M 28.95M 13.8M
Australia Revenue Growth +40.54% -99.33% +14.86% +109.82% n/a
European Union Revenue 155K 51K n/a n/a n/a
European Union Revenue Growth +203.92% n/a n/a n/a n/a
Japan Revenue 1.43M 3.37M n/a n/a n/a
Japan Revenue Growth -57.54% n/a n/a n/a n/a
United States Revenue 62.16M 46.36M n/a n/a n/a
United States Revenue Growth +34.08% n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 20.98M 21.22M 21.23M 24.73M 23.82M 21.6M 17.97M 25.78M 15.95M 14.84M 17.13M 16.28M 10.6M 12.15M 14.53M 8.87M 9.42M 8.87M 6.8M 11.38M 13.78M 27.91M 15.79M 9.93M 8.49M 8.62M 5.23M 5.36M 7.36M 3.73M 2.5M 2.52M 3.25M 3.23M 1.97M 2.09M 2.32M 2.4M 1.71M 1.65M 968.42K 959.7K
Selling, General, and Administrative Revenue Growth -1.15% -0.04% -14.15% +3.83% +10.27% +20.24% -30.31% +61.62% +7.52% -13.41% +5.21% +53.68% -12.83% -16.36% +63.89% -5.88% +6.18% +30.39% -40.20% -17.43% -50.61% +76.74% +58.94% +17.01% -1.53% +64.97% -2.54% -27.16% +97.27% +49.08% -0.50% -22.47% +0.60% +63.84% -5.73% -10.11% -3.07% +40.27% +3.59% +70.35% +0.91% n/a
Research and Development Revenue 5.12M 6.28M 4.85M 5.43M 4.89M 5.19M 6.76M 6.84M 7.62M 6.86M 4.96M 5.94M 4.43M 4.84M 5.78M 3.39M 3.97M 5.41M 4.36M 4.71M 3.68M 4.06M 3.3M 2.42M 1.55M 1.42M 2.49M 2.56M 275.78K 2.9M 1.97M 1.98M 1.44M 1.43M 908.23K 963.39K 711.07K 733.59K 563.96K 544.42K 1.09M 1.08M
Research and Development Revenue Growth -18.57% +29.57% -10.65% +11.07% -5.91% -23.22% -1.03% -10.31% +11.10% +38.21% -16.44% +34.06% -8.41% -16.27% +70.53% -14.75% -26.54% +24.09% -7.50% +28.15% -9.36% +23.13% +36.02% +55.80% +9.28% -42.94% -2.54% +827.74% -90.49% +46.89% -0.50% +37.50% +0.60% +57.89% -5.73% +35.48% -3.07% +30.08% +3.59% -49.89% +0.91% n/a
Sales and Marketing Revenue 14.31M 14.83M 14.11M 15.14M 16.3M 12.64M 10.22M 16.38M 9.79M 6.54M 9.32M 8.46M 5.33M 4.83M 6.82M 3.52M 4.15M 3.65M 3.6M 3.27M 4.26M 7.11M 5.66M 4.39M 3.96M 3.67M 2.44M 2.5M 528.79K 2.35M 1.1M 1.1M 1.29M 1.29M 662.14K 702.35K 726.07K 749.06K 550.85K 531.76K 741.68K 735K
Sales and Marketing Revenue Growth -3.51% +5.14% -6.83% -7.10% +28.97% +23.73% -37.64% +67.30% +49.74% -29.80% +10.11% +58.67% +10.44% -29.19% +93.81% -15.15% +13.62% +1.36% +10.26% -23.36% -40.12% +25.67% +28.99% +10.76% +8.07% +50.19% -2.54% +373.68% -77.51% +114.01% -0.50% -14.66% +0.60% +94.22% -5.73% -3.27% -3.07% +35.98% +3.59% -28.30% +0.91% n/a